News & Analysis as of

Emerging Technologies Biotechnology

McDermott Will & Emery

Key Takeaways | Pharma and MedTech Manufacturing and Contract Development

McDermott Will & Emery on

During the session, the panelists discussed investment strategies in the Contract Development and Manufacturing Organization (CDMO) space, emphasizing factors like supply and demand dynamics, quality control, and the impact...more

American Conference Institute (ACI)

[Event] FCPA & Anti-Corruption for the Life Sciences Industry - May 9th - 10th, New York, NY

Hosted by the American Conference Institute, the 19th Annual FCPA & Anti-Corruption Conference for the Life Sciences Industry returns for another exciting year with carefully researched programming based on critical findings...more

Maynard Nexsen

Taking the Pulse, A Health Care and Life Sciences Video Podcast | Episode 154: Andy Schwartzkopf, General Counsel and Chief...

Maynard Nexsen on

On episode 154, Heather and Lauren welcome Andy Schwartzkopf, General Counsel and Chief Administration Officer for Signature Medical Group, one of the largest private, multi-specialty medical groups in the Midwest. Tune in to...more

MoFo Life Sciences

The Legal And Regulatory Landscape Evolving With AI In Life Sciences

MoFo Life Sciences on

In the last ten years, more data and greater computing power have led to a boom in AI-related patent applications, with life and medical sciences emerging as a top application field. In 2021, more than 100 applications...more

TransPerfect Legal

The Legal and Regulatory Landscape Evolving with AI in Life Sciences

TransPerfect Legal on

In the last ten years, more data and greater computing power have led to a boom in AI-related patent applications, with life and medical sciences emerging as a top application field. In 2021, more than 100 applications...more

Wiley Rein LLP

[Podcast] Keith Matthews and Chris Wozniak: Talking Ag Biotech Episode 2

Wiley Rein LLP on

In this second episode of the Talking Ag Biotech podcast on regulatory policies and procedures impacting agricultural biotechnology, Keith Matthews and Chris Wozniak discuss President Biden’s recent Executive Order on...more

Sheppard Mullin Richter & Hampton LLP

Takeaways From the U.S. Patent and Trademark Office’s Artificial Intelligence and Emerging Technologies Partnership Series – Part...

On September 22, 2022, the U.S. Patent and Trademark Office (USPTO) conducted a live meeting for its Artificial Intelligence (AI) and Emerging Technologies (ET) Partnership Series. During this meeting, panelists from industry...more

Wiley Rein LLP

President Biden Signs Executive Order 14081 to Promote Biotechnology and Biomanufacturing

Wiley Rein LLP on

In the latest of a series of Presidential actions intended to promote biotechnology and confirm the continued support of advances in biotechnology as official policy of the United States, on September 12, 2022, President Joe...more

Wilson Sonsini Goodrich & Rosati

2021 Mid-Year Technology and Life Sciences IPO Report

Wilson Sonsini Goodrich & Rosati’s 2021 Mid-Year Technology and Life Sciences IPO Report presents analyses related to the pricing of 123 initial public offerings completed by U.S.-based technology and life sciences companies...more

Wiley Rein LLP

Recent Actions on Ag Biotech by EPA’s Emerging Technologies Branch

Wiley Rein LLP on

In this webinar, Keith Matthews from Wiley's Environment & Product Regulation group discusses recent actions by the U.S. Environmental Protection Agency (EPA) Biopesticides and Pollution Prevention Division's (BPPD) Emerging...more

10 Results
 / 
View per page
Page: of 1

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
- hide
- hide